Skip to main content

On to Meaningful Use Stage 2: Refining Public Health Readiness Guidelines


In the U.S., federal programs are accelerating the meaningful use of electronic health record (EHR) technology and encouraging greater standardization in how governmental public health agencies (PHAs) establish surveillance data partnerships with healthcare providers. To qualify for the benefits of these federal programs (a.k.a., Meaningful Use), healthcare professionals and hospitals must determine: 1) Whether their jurisdictional PHA collects health data for immunization or cancer registries, reportable diseases, and/or syndromic surveillance; and 2) If the PHA does collect this data, then they must register for data on-boarding with the PHA and actively work with them to establish on-going data exchange. These requirements are predicated on participating state and local PHAs either establishing new or expanding the capacity of their existing public health data reporting services. To assist state and local PHAs in this effort, the U.S. Centers for Disease Control and Prevention (CDC) facilitates a national task force, known as the Stage 2 MU Public Health Reporting Requirements Task Force, which has recommended guidelines and clarified requirements for these new processes.


To exchange lessons learned and refine national guidelines for public health agencies to declare Meaningful Use readiness, register eligible professionals and hospitals for the public health meaningful use objectives, on-board data providers, and perform "on-going" data submission.

Submitted by elamb on